You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lp(a)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphedema Trial in Nice (lipoprotein (a))

Not yet recruiting
  • Lymphedema
  • lipoprotein (a)
  • Nice, Centre Antoine Lacassagne, France
    CAUSERET Marion
Jul 19, 2023

Lipoprotein(a) and Endogenous Fibrinolysis in Atherosclerotic

Recruiting
  • Atherosclerosis
  • Aortic Valve Disease
  • Thrombotic assessment
  • Measurement of Lp(a)
  • Stevenage, United Kingdom
    East and North Herts NHS Trust
Nov 6, 2023

Relapsed or Refractory Lymphomas, Advanced Solid Tumor Trial in Los Alamitos (LP-284)

Not yet recruiting
  • Relapsed or Refractory Lymphomas
  • Advanced Solid Tumor
  • Los Alamitos, California
    Cancer and Blood Specialty Clinic
Nov 9, 2023

Hiv Trial (LP-98 injection)

Not yet recruiting
  • Hiv
  • LP-98 injection
  • (no location specified)
Jun 27, 2023

Mantle Cell Lymphoma Trial in Hangzhou (LP-168 tablet)

Recruiting
  • Mantle Cell Lymphoma
  • LP-168 tablet
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Jun 24, 2023

Post-Lumbar Puncture Headache Trial in Houston (Modified Lumbar Puncture)

Not yet recruiting
  • Post-Lumbar Puncture Headache
  • Modified Lumbar Puncture
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Oct 3, 2023

Lp(a) With CCTA Assessed Parameters and Clinical Outcomes

Recruiting
  • Coronary Artery Disease
  • Coronary CTA
  • Shanghai, China
    Shanghai Zhongshan Hospital
Apr 4, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial (LP-108, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • (no location specified)
Nov 29, 2022

Chronic Hepatitis b Trial in Guangzhou (LP-128 capsules, Matching Placebo)

Recruiting
  • Chronic Hepatitis b
  • LP-128 capsules
  • Matching Placebo
  • Guangzhou, Guangdong, China
    NanFang Hospital of Southern Medical University
Aug 2, 2022

Acute Coronary Syndrome, Lipoproteinemia, Inflammation Trial in Ljubljana (Pelacarsen (TQJ230), Placebo)

Withdrawn
  • Acute Coronary Syndrome
  • +3 more
  • Pelacarsen (TQJ230)
  • Placebo
  • Ljubljana, Slovenia
    University Medical Centre Ljubljana-Department of Vascular disea
Dec 10, 2021

Multiple Sclerosis, NMO Spectrum Disorder Trial in Hangzhou (LP-168 tablet, LP-168 Placebo tablet)

Recruiting
  • Multiple Sclerosis
  • NMO Spectrum Disorder
  • LP-168 tablet
  • LP-168 Placebo tablet
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital Zhejiang University School of Med
Jun 26, 2022

Pediatric, Bacterial Infections Trial in Cincinnati (amoxicillin-clavulanic acid)

Not yet recruiting
  • Pediatric
  • Bacterial Infections
  • amoxicillin-clavulanic acid
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Oct 14, 2022

Aortic Stenosis Trial (Pelacarsen (TQJ230) 80mg, Matching )

Not yet recruiting
  • Aortic Stenosis
  • Pelacarsen (TQJ230) 80mg
  • Matching placebo
  • (no location specified)
Dec 2, 2022

Seasonal Allergic Rhinitis Trial in China (LP-003 dose 1, LP-003 dose 2, Placebo)

Recruiting
  • Seasonal Allergic Rhinitis
  • LP-003 dose 1
  • +2 more
  • Beijing, Beijing, China
  • +16 more
Sep 18, 2023

Hemorrhagic Cystitis Trial in United States (LP-10)

Active, not recruiting
  • Hemorrhagic Cystitis
  • Tucson, Arizona
  • +8 more
Jan 9, 2023

Cholesterol; Metabolic Disorder, Lipoproteinemia Trial in Nantes (infusion of tracer [5,5,5-2H3] -L-leucine)

Completed
  • Cholesterol; Metabolic Disorder
  • Lipoproteinemia
  • infusion of tracer [5,5,5-2H3] -L-leucine
  • Nantes, France
    Nantes University Hospital
Feb 22, 2022

Adenocarcinoma of Lung, NSCLC Trial in Rolling Meadows (LP-300, Pemetrexed, Carboplatin)

Not yet recruiting
  • Adenocarcinoma of Lung
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Jul 8, 2022

CLL/SLL, Waldenstrom Macroglobulinemia, Follicular Lymphoma Trial in Cincinnati, Columbus, Salt Lake City (LP-168)

Recruiting
  • CLL/SLL
  • +6 more
  • Cincinnati, Ohio
  • +2 more
May 7, 2022

Adult Glioblastoma Trial in Gainesville (Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane

Recruiting
  • Adult Glioblastoma
  • Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane protein (LAMP) mRNA loaded DOTAP liposome vaccine administered intravenously (RNA loaded lipid particles, RNA-LPs)
  • Gainesville, Florida
    UF Health
Aug 30, 2022

B-cell Lymphoma Trial in Beijing, Guangzhou (LP-168 tablet)

Recruiting
  • B-cell Lymphoma
  • LP-168 tablet
  • Beijing, Beijing, China
  • +2 more
Feb 24, 2022

Chronic Kidney Disease Stage 3B, Chronic Kidney Disease stage4, Chronic Kidney Disease Stage 5 Trial in France (Consumption of

Not yet recruiting
  • Chronic Kidney Disease Stage 3B
  • +2 more
  • Consumption of FLAVIS
  • Aix-en-Provence, France
  • +8 more
Aug 4, 2022

Healthy Participants Trial in Las Vegas, Austin (TAK-510, TAK-510 Placebo)

Completed
  • Healthy Participants
  • Las Vegas, Nevada
  • +1 more
Oct 21, 2022

Hyperlipidemias, Dyslipidemias, Elevated Lp(a) Trial in Worldwide (SLN360, Placebo)

Recruiting
  • Hyperlipidemias
  • +2 more
  • Jacksonville, Florida
  • +6 more
Mar 18, 2022

Hand Hygiene Effectiveness Trial in Northfield (Alcohol hand sanitizer foam)

Completed
  • Hand Hygiene Effectiveness
  • Alcohol hand sanitizer foam
  • Northfield, Illinois
    Medline Industries, LP
Feb 22, 2023

Solid Tumor, Lymphoma, B-Cell Trial in Guangzhou (LP-118 tablet)

Recruiting
  • Solid Tumor
  • Lymphoma, B-Cell
  • LP-118 tablet
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Sep 15, 2021